Tema Oncology ETF CANC | NASDAQ

CANC last paid $0.0196 a share on Dec 12, 2025, and returned 13.7% over 12 months with distributions counted. · 1-year total return +13.7% · Track CANC in a free portfolio

Dividends

Company Overview:

Market Cap: $122.25M
Trailing PE: N/A
FWD PE: —
Payout Ratio (TTM): —
52-Week Range: $33.43 - $47.00

3.3 Year CANC Performance Metrics:

Total Return (with DRIP): 997% (108.21% CAGR)
Total Return (no DRIP): 984% (107.45% CAGR)
Share Price: 960% (105.99% CAGR)
Yield on Cost (with DRIP): 0.56%
Total Invested: $10,000
Total Value (with DRIP): $109,727
Total Return $ (with DRIP): $99,727
Dividend Increase: 0.0% (0.00% CAGR)
Dividend Yield (FWD): 0.05% ($0.02)
CANC 3.3-yr Total Return ($10K invested)
1M 3M 6M YTD 1Y 3Y 5Y 10Y
CANC Share Price
1M 3M 6M YTD 1Y 3Y 5Y 10Y All
CANC Price CAGR:1Y: 13.68%2Y: 21.38%5Y: 105.99%10Y: 105.99%

CANC Dividend Payments & Yield

Dividend Payments & Yield
CANC Dividend CAGR:1Y: -97.31%2Y: -63.75%5Y: -63.88%10Y: -63.88%
Annual Dividends (Total Paid Per Year)
Dividend Growth Year Over Year

Compare stocks side-by-side

CANC Dividends Info:

Annual Dividend: $0.0195905
Forward Yield: 0.05%
Ex-Dividend Date: 2025-12-10
Lifetime Dividends / Share: $0.90

Projected Future Returns & Dividends for CANC

Based on past 3.3-year performance, here are CANC growth metrics:

Share price CAGR of +104.48%
Dividend CAGR of -63.88%

Using CANC CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:

CANC (DRIP)CANC - No DRIP
Current Price$38.57$38.57
Start Shares259.27259.27
Start Value$10,000$10,000
  
After 10 years:
Final Share Count259.47259.27
Dividends Payment$0.00$0.00
Annual Dividends$0$0
Yield on cost0.00%0.00%
Share Price$38.57$38.57
Total Dividends$8$8
Final Value$10,008$10,008

Estimated Future Value + Dividends - CANC

NOTE: Above numbers are our estimate based on CANC's Dividend and Price CAGR over past 3.3 years. These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.

We cannot guarantee that your actual returns will meet these estimates.

Company Info

Tema Oncology ETF (CANC) had its IPO on 2023-08-14, and is traded on NASDAQ stock exchange.

The Tema Oncology ETF (CANC) is designed to strategically invest in companies well-positioned to capitalize on significant advancements within cancer-focused biotechnology and the broader healthcare sector.

CANC website: https://temaetfs.com/canc


Loading signals…

DCF model unavailable for CANC — no fundamentals on file (ETFs and funds are not modelable).